SDIX LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:SDIX LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11426
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SDIX LLC (SDIX), a subsidiary of OriGene Technologies Inc, is an immuno-solutions company that develops antibody-based solutions. The company provides IVD solutions and premade antibiotics, among others. Its IVD solutions provide co-development of analyte-specific reagents, diagnostic menu expansion clinical assays, and custom formulation of IVD reagents, large scale production and bioprocessing, among others. SDIX’s cell machinery offers presentation of the epitopes in the native conformation, thus yielding highly reactive antibodies to the native structure of the protein. The company also offers antibody development, antibody production and services and assay development, among others. It serves IVD, anatomic pathology, biotechnology and pharmaceutical markets. SDIX is headquartered in Newark, Delaware, the US.

SDIX LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SDIX LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SDIX LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
SDIX LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SDIX LLC, Medical Equipment, Deal Details 10
Partnerships 10
SDIX Enters Into Licensing Agreement With BD Diagnostic 10
Asset Transactions 11
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 11
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 13
SDIX LLC – Key Competitors 14
SDIX LLC – Key Employees 15
SDIX LLC – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
SDIX LLC, Medical Equipment, Key Facts 2
SDIX LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SDIX LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SDIX LLC, Deals By Market, 2012 to YTD 2018 8
SDIX LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
SDIX Enters Into Licensing Agreement With BD Diagnostic 10
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 11
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 13
SDIX LLC, Key Competitors 14
SDIX LLC, Key Employees 15

List of Figures
SDIX LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
SDIX LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
SDIX LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
SDIX LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
SDIX LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[SDIX LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fraser and Neave, Limited:企業の戦略・SWOT・財務情報
    Fraser and Neave, Limited - Strategy, SWOT and Corporate Finance Report Summary Fraser and Neave, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • FHI 360:企業の戦略的SWOT分析
    FHI 360 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Senju Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Senju Pharmaceutical Co Ltd (Senju) researches, develops, manufactures and markets pharmaceutical products for eye, ear, nose, throat, and skin. The company offers a wide range of ophthalmological products. Its product portfolio includes prescription products, OTC medicines and veterinary dr …
  • Marriott International Inc:企業のM&A・事業提携・投資動向
    Marriott International Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marriott International Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Sarossa plc-製薬・医療分野:企業M&A・提携分析
    Summary Sarossa plc (Sarossa), formerly Sarossa Capital Limited, is an investment holding and management company. The company principally makes investment in and growth and development of businesses which present opportunities for value creation. It focuses on portfolio investment in major internati …
  • PAR Technology Corp (PAR):企業の財務・戦略的SWOT分析
    Summary PAR Technology Corp (PAR) is a technology company that offers systems and solutions for the hospitality industry. The company offers services such as project management, education services, deployment services, on-site field services, depot repair, and managed services. It also implements fo …
  • Neptune Orient Lines Limited:企業の戦略・SWOT・財務情報
    Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report Summary Neptune Orient Lines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Banco ABC Brasil SA (ABCB4):企業の財務・戦略的SWOT分析
    Banco ABC Brasil SA (ABCB4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tennessee Valley Authority:企業の発電所・SWOT分析2018
    Tennessee Valley Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Neptune Technologies & Bioressources Inc:企業のM&A・事業提携・投資動向
    Neptune Technologies & Bioressources Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Neptune Technologies & Bioressources Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed …
  • MILEI GmbH:企業の戦略・SWOT・財務情報
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Heptares Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Heptares Therapeutics Ltd (Heptares), a subsidiary of Sosei Group Corp is a drug discovery company that develops small-molecule drugs. The company develops drugs for targeting G-protein-coupled receptors by utilizing its drug discovery technology platforms. Its technology platforms comprise …
  • Haverty Furniture Companies, Inc. (HVT):企業の財務・戦略的SWOT分析
    Haverty Furniture Companies, Inc. (HVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Motor Oil (Hellas) Corinth Refineries SA (MOH):企業の財務・戦略的SWOT分析
    Motor Oil (Hellas) Corinth Refineries SA (MOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • DJO Finance LLC:企業の戦略的SWOT分析
    DJO Finance LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • ADDvise Group AB (ADDV A):医療機器:M&Aディール及び事業提携情報
    Summary ADDvise Group AB (ADDvise), formerly ADDvise Lab Solutions AB, is a medical device company that manufactures and markets healthcare and laboratory equipment. The company offers laboratory products such as laboratory equipments, furnishings, safety ventilation, centrifuges, climate chambers, …
  • ICI Pakistan Ltd (ICI):企業の財務・戦略的SWOT分析
    ICI Pakistan Ltd (ICI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • NuGEN Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary NuGEN Technologies Inc (NuGEN) is a provider of biological science reagents. The company offers DNA and RNA sample preparation products for use in research and diagnostic applications. Its products include Next-Gen Sequencing applications, which include RNA-Seq, targeted resequencing of DNA …
  • Forma Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Forma Therapeutics Inc (Forma) is a drug discovery and development company that discovers and develops new transformative cancer therapeutics. The company develops technologies to identify the initial molecules that provide drug discovery program. It offers research in the areas of tumor met …
  • AMW GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary AMW GmbH (AMW) is a pharmaceutical company that develops and manufactures drug delivery systems for treatment in the areas of oncology, neurology, dermatology and pain. The company designs and develops novel transdermal drug delivery systems, microchip controlled patches and biodegradable su …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆